Company Filing History:
7 out of 146 
7 out of 42 
1 out of 115 
Years Active: 2009-2023
Title: Robert Arjen Kramer: Innovative Biotechnologist and Patent Genius
Introduction:
In the field of biotechnology, inventors and researchers play a vital role in shaping the industry through their innovative ideas and patents. One such exceptional individual is Robert Arjen Kramer, a distinguished inventor and biotechnologist hailing from Utrecht, Netherlands. With an impressive track record and a passion for advancing scientific knowledge, Kramer has made significant contributions to the biotech sector, particularly in the realm of antibody production. This article aims to shed light on his latest patents, career highlights, collaborations, and the impact he has made in his field.
Latest Patents:
Robert Arjen Kramer is known for his groundbreaking work in developing transgenic, non-human animals capable of producing antibodies. His latest patents focus on these remarkable inventions. The first patent, entitled "Antibody Producing Non-Human Animals," describes the creation of transgenic animals carrying a nucleic acid encoding an immunoglobulin light chain. This chain may be human, human-like, or humanized. The nucleic acid is designed to be resistant to DNA rearrangements and somatic hypermutations. Additionally, the patent reveals methods for producing immunoglobulins from these transgenic animals.
Career Highlights:
Throughout his career, Kramer has made valuable contributions to various companies in the biotech industry. He has been associated with highly regarded institutions such as Crucell Holland B.V. and Merus N.V. While specific details about his roles and accomplishments within these companies are not available, his work undoubtedly revolved around advancing biotechnological research and development.
Collaborations:
Collaboration is an integral part of scientific progress, and Robert Arjen Kramer has been fortunate to work alongside some eminent individuals in his field. Notable coworkers include Cornelis Adriaan De Kruif and Mark Throsby. Although the nature of their collaborations remains undisclosed, it can be inferred that together they have made significant breakthroughs in the field of biotechnology.
Conclusion:
The remarkable career of Robert Arjen Kramer, a biotechnologist and inventor from Utrecht, Netherlands, is a testament to his immense talent and dedication. His pioneering patents in antibody production showcase his ability to push the boundaries of scientific knowledge. Through his affiliations with renowned companies such as Crucell Holland B.V. and Merus N.V., Kramer has left an indelible mark on the biotech industry. Collaborations with esteemed coworkers Cornelis Adriaan De Kruif and Mark Throsby further highlight the power of teamwork and knowledge sharing in scientific advancements. As we eagerly anticipate his future contributions, it is clear that Robert Arjen Kramer embodies the spirit of innovation and remains an influential figure in the world of biotechnology.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.